Subclinical hypothyroidism and risk for incident ischemic stroke among postmenopausal women

Thyroid

Volumn 24, Issue 8, 2014, Pages 1210-1217

  Giri, Ayush ^a   Edwards, Todd L ^a   Legrys, Vicky A ^b   Lorenz, Carol E ^c   Funk, Michele Jonsson ^c   Schectman, Robin ^d   Heiss, Gerardo ^c   Robinson, Jennifer G ^e   Hartmann, Katherine E ^a,f  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; HAZARD RATIO; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; HYPOTHYROIDISM; ISCHEMIA; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; ISCHEMIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY AS TOPIC; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; THYROTROPIN; THYROXINE;

EID: 84904697073     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0106     Document Type: Article

References (40)

1. McDermott MT 2001 Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab 86:4585-4590. (Pubitemid 33020489)
2. Bagchi N, Brown TR, Parish RF 1990 Thyroid dysfunction in adults over age 55 years: a study in an urban US community. Arch Intern Med 150:785-787. (Pubitemid 20122054)
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534. (Pubitemid 30112276)
4. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Evans JG, Hasan DM, Rodgers H, Bridge F, Young ET 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 43:55-68.
5. Helfand M 2004 Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 140:128-141.
6. Stone MB, Wallace RB 2003 Medicare coverage of routine screening for thyroid dysfunction. National Academies Press, Washington, DC.
7. Tseng FY, Lin WY, Lin CC, Lee LT, Li TC, Sung PK, Huang KC 2012 Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J Am Coll Cardiol 60:730-737.
8. Rodondi N, den Elzen WPJ, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MPJ, Newman AB, Cornuz J, Franklyn JA, Westendorp RGJ, Vittinghoff E, Gussekloo J 2010 Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365-1374.
9. Razvi S, Weaver JU, Vanderpump MP, Pearce SHS 2010 The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metabol 95:1734-1740.
10. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467-2472. (Pubitemid 41720007)
11. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270-278. (Pubitemid 30106257)
12. Pearce EN 2012 Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97:326-333.
13. LeGrys VA, Funk MJ, Lorenz CE, Giri A, Jackson RD, Manson JE, Schectman R, Edwards TL, Heiss G, Hartmann KE 2013 Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. J Clin Endocrinol Metab 98:2308-2317.
14. The Women's Health Initiative Study Group 1998 Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 109:61-109.
15. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC 2005 Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460-2466. (Pubitemid 41720006)
16. Schultz M, Kistorp C, Raymond I, Dimsits J, Tuxen C, Hildebrandt P, Faber J 2011 Cardiovascular events in thyroid disease: a population based, prospective study. Horm Metab Res 43:653-659.
17. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M 2003 The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13: S107-S121. (Pubitemid 37324180)
18. Curb JD, Mctiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, others 2003 Outcomes Ascertainment And Adjudication Methods In the Women's Health Initiative. Ann Epidemiol 13:122-128.
19. Barlow WE, Ichikawa L, Rosner D, Izumi S 1999 Analysis of case-cohort designs. J Clin Epidemiol 52:1165-1172. (Pubitemid 29535416)
20. Lin DY, Wei LJ 1989 The robust inference for the Cox proportional hazards model. JASA 84:1074-1078.
21. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033-1041.
22. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K 2004 Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89:3365-3370. (Pubitemid 38951905)
23. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Mü ller B 2003 Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166:379-386. (Pubitemid 36071697)
24. Ichiki T 2010 Thyroid hormone and atherosclerosis. Vascul Pharmacol 52:151-156.
25. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH 2001 Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 155:195-200. (Pubitemid 32167140)
26. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM 1997 Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 82:3421-3424. (Pubitemid 27419098)
27. Tian L, Gao C, Liu J, Zhang X 2010 Increased carotid arterial stiffness in subclinical hypothyroidism. Eur J Intern Med 21:560-563.
28. Iqbal A, Jorde R, Figenschau Y 2006 Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Troms+ + study. J Intern Med 260:53-61. (Pubitemid 43894070)
29. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2005 Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol 63:670-675. (Pubitemid 41779641)
30. Monzani F, Di V, Caraccio N, Bertini A, Giorgi D, Giusti C, Ferrannini E 2001 Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 86:1110-1115. (Pubitemid 32322990)
31. Kim JH, Park JH, Kim SY, Bae HY 2013 The mean platelet volume is positively correlated with serum thyrotropin concentrations in a population of healthy subjects and subjects with unsuspected subclinical hypothyroidism. Thyroid 23: 31-37.
32. Duntas LH, Mantzou E, Koutras DA 2002 Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 12:1003-1007. (Pubitemid 35404135)
33. Danese MD 2000 Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clini Endocrinol Metab 85:2993-3001.
34. Shakoor SKA, Aldibbiat A, Ingoe LE, Campbell SC, Sibal L, Shaw J, Home PD, Razvi S, Weaver JU 2010 Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab 95:319-322.
35. McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ 2011 Hypothyroidism and moderate subclinical hypothyroidism are associated with increased allcause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid 21:837-843.
36. Auer J, Berent R, Weber T, Lassnig E, Eber B 2003 Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 26:569-573. (Pubitemid 37486836)
37. Bruckert E, Giral P, Chadarevian R, Turpin G 1999 Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients. Journal of cardiovascular risk 6:327-331. (Pubitemid 30025629)
38. Arafah BM 2001 Increased need for thyroxine in women with hypothyroidism during estrogen therapy. New Engl J Med 344:1743-1749. (Pubitemid 32497028)
39. Somwaru LL, Rariy CM, Arnold AM, Cappola AR 2012 The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 97:1962-1969.
40. Quinn TJ, Gussekloo J, Kearney P, Rodondi N, Stott DJ 2012 Subclinical thyroid disorders. Lancet 380:335-336.